Gwyneth Paltrow’s Goop under fire again for ‘exploiting health issues in order to make money’

| | February 10, 2020
e eeccab fd f
Image: Gwyneth Paltrow
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Gwyneth Paltrow’s contextual commerce company Goop is still making more than a dozen false and misleading health claims about the medical products and nutritional supplements it sells, according to a complaint letter from the nonprofit advertising watchdog Truth in Advertising, Inc.

The bogus health claims are not just potential hazards to consumers, they are direct violations of a court order that bars Goop from making such false and misleading claims, the watchdog alleges.

That court order was part of a legal settlement Goop entered in September 2018 to resolve a lawsuit brought by 10 California District Attorney offices.

“Goop seems to have forgotten that it is legally bound by a court order to refrain from engaging in deceptive marketing or, worse, is knowingly violating the order,” Bonnie Patten,’s Executive Director, said in a statement. “It is outrageous that Goop continues to exploit health issues in order to make money.”

Related article:  Using stem cells to trace autism's development to earliest days of pregnancy

In its new complaint letter to District Attorneys in California, alleges that in more than a dozen instances, Goop “deceptively markets products as able to treat and/or mitigate the symptoms of several medical conditions, including anxiety, depression, OCD, hormone imbalances, and hair loss, as well as address the symptoms of excessive alcohol consumption.”

Read the original post

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend